Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients

BACKGROUND AND OBJECTIVES: Belatacept is a first-in-class, selective co-stimulation blocker recently approved for the prophylaxis of organ rejection in adult kidney transplant recipients. The objective of this study was to report the pharmacokinetics, pharmacodynamics, and immunogenicity of belatace...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Shen, Jinshan, Townsend, Robert, You, Xiaoli, Shen, Yun, Zhan, Ping, Zhou, Zexun, Geng, Dong, Wu, Dianna, McGirr, Nadia, Soucek, Kathleen, Proszynski, Elizabeth, Pursley, Janice, Masson, Eric
Format: Artigo
Język:Inglês
Wydane: Springer International Publishing 2013
Hasła przedmiotowe:
Original Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899455/
https://ncbi.nlm.nih.gov/pubmed/24217983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-013-0153-2
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy